Breaking News

Over a month ago Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
On The Fly	Fly Intel: After-Hours Movers » 19:06 02/01/23 02/01 19:06 02/01/23 19:06 META Meta Platforms $153.10 / +4.135 (+2.78%) , ALGN Align Technology $282.22 / +12.72 (+4.72%) , ELF e.l.f. Beauty $58.56 / +0.94 (+1.63%) , EZPW Ezcorp $9.02 / -0.08 (-0.88%) , EGHT 8x8 $5.01 / +0.285 (+6.03%) , IVAC Intevac $6.80 / -0.06 (-0.87%) , HOLX Hologic $82.85 / +1.47 (+1.81%) , CLB Core Laboratories $25.86 / +0.29 (+1.13%) , MCK McKesson $370.85 / -7.73 (-2.04%) , TENX Tenax Therapeutics $1.70 / -0.37 (-17.87%) , CHX ChampionX $32.47 / -0.54 (-1.64%) , MXL MaxLinear $43.25 / +2 (+4.85%) , PTC PTC $137.98 / +3.15 (+2.34%) , CHRW C.H. Robinson $101.99 / +1.755 (+1.75%) , CTVA Corteva $64.47 / +0.015 (+0.02%) , QRVO Qorvo $113.56 / +4.91 (+4.52%) , CCS Century Communities $63.32 / +2.215 (+3.63%) , VERA Vera Therapeutics $8.47 / -0.01 (-0.12%) , ROIV Roivant Sciences $8.57 / +0.275 (+3.32%) Check out this evening's… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options VERA TENX ROIV QRVO PTC MXL META MCK IVAC HOLX EZPW ELF EGHT CTVA CLB CHX CHRW CCS ALGN VERA Vera Therapeutics $8.47 / -0.01 (-0.12%) 01/30/23 Vera Therapeutics reports Phase 2 results of atacicept in IgA nephropathy 01/25/23 Vera Therapeutics to host KOL webinar on atacicept 01/03/23 Vera Therapeutics shares fall 67% despite ORIGIN trial meeting primary endpoint 01/03/23 Vera Therapeutics announces ORIGIN clinical trial met primary endpoint TENX Tenax Therapeutics $1.70 / -0.37 (-17.87%) 02/01/23 Tenax receives NOA from USPTO for patent for levosimendan in PH-HFpEF 01/04/23 Tenax Therapeutics announces 1-for-20 reverse stock split 10/10/22 Tenax Therapeutics announces presentation of data from study of levosimendan 09/15/22 Tenax Therapeutics trading resumes ROIV Roivant Sciences $8.57 / +0.275 (+3.32%) 01/04/23 Roivant Sciences up 9% in pre-market at $7.78 after RVT-3101 phase 2b study data 01/04/23 Roivant Sciences announces 'positive' results from Phase 2b study of RVT-3101 12/01/22 Roivant Sciences, Pfizer form new Vant company focused on developing RVT-3101 11/10/22 Roivant's Affivant to present data on AFVT-2101 at SITC QRVO Qorvo $113.56 / +4.91 (+4.52%) 11/28/22 Qorvo partners with MediaTek to secure design wins 11/02/22 Qorvo, SK Siltron CSS enter SiC supply agreement 11/02/22 Qorvo announces $2B share repurchase program 08/30/22 Qorvo appoints Grant Brown as CFO PTC PTC $137.98 / +3.15 (+2.34%) 11/17/22 PTC to acquire ServiceMax for $1.46B in cash 11/14/22 Lone Pine adds Autodesk stake, reduces Meta Platforms, Microsoft stakes MXL MaxLinear $43.25 / +2 (+4.85%) 10/19/22 MaxLinear, SoftAtHome team on prpl LCM solution for home gateways 09/01/22 Digi International selects MaxLinear PCIe bridges, serial transceivers 08/31/22 Silicon Motion shareholders approve acquisition by MaxLinear META Meta Platforms $153.10 / +4.135 (+2.78%) 02/01/23 Meta cuts FY23 total expenses view to $89B-$95B from $94B-$100B 02/01/23 Meta says 2023 will be 'a year of efficiency' 02/01/23 Meta Platforms announces $40B increase in share repurchase authorization 02/01/23 Meta Platforms reports FoA and RL segment restructuring charges MCK McKesson $370.85 / -7.73 (-2.04%) 09/29/22 McKesson extends pharmaceutical distribution agreement with CVS Health 09/19/22 McKesson signs agreement to acquire Rx Savings Solutions 09/19/22 McKesson to acquire Rx Savings Solutions for $600M upfront 09/13/22 McKesson names LeAnn Smith chief human resources officer IVAC Intevac $6.80 / -0.06 (-0.87%) 12/30/22 Intevac signs joint development agreement with glass, glass ceramic provider 10/26/22 Intevac gets $12M order for hard disk drive technology upgrades HOLX Hologic $82.85 / +1.47 (+1.81%) 12/06/22 Hologic's new data identifies patients benefiting from endocrine therapy 11/25/22 Hologic to showcase portfolio of breast, skeletal health solutions at RSNA 2022 11/02/22 Hologic awarded $19M BARDA contract 10/23/22 Fly Intel: Top five weekend stock stories EZPW Ezcorp $9.02 / -0.08 (-0.88%) 12/05/22 Ezcorp increases investment in Florida and Caribbean 11/17/22 EZCORP trading resumes 11/17/22 EZCORP trading halted, volatility trading pause 08/22/22 Ezcorp launches Buy More, Earn More promotion ELF e.l.f. Beauty $58.56 / +0.94 (+1.63%) 11/03/22 e.l.f. Beauty rises 10.2% EGHT 8x8 $5.01 / +0.285 (+6.03%) 01/18/23 8x8 announces approximately 7% reduction in workforce 12/13/22 Matterport appoints Matthew Zinn as chief legal officer 12/08/22 Spearline acquires Callstats from 8x8, terms not disclosed 11/30/22 8x8 terminates CEO Dave Sipes, Samuel Wilson named interim CEO CTVA Corteva $64.47 / +0.015 (+0.02%) 12/20/22 Corteva Agriscience, Nevonex announce collaboration agreement 11/30/22 Corteva to acquire Stoller Group for $1.2B 11/14/22 Starboard takes stake in Wix.com, exits Elanco Animal Health 10/03/22 Syngenta, Corteva sued by FTC for pay-to-black scheme CLB Core Laboratories $25.86 / +0.29 (+1.13%) 01/17/23 Core Laboratories proposes redomestication of parent company to U.S. 10/26/22 Core Laboratories CEO sees progress in onshore and offshore client activity CHX ChampionX $32.47 / -0.54 (-1.64%) 10/05/22 ChampionX's US Synthetic weighs challenge to patent ruling 09/29/22 ChampionX publishes first sustainability report CHRW C.H. Robinson $101.99 / +1.755 (+1.75%) 02/01/23 C.H. Robinson sees 2023 capital expenditures $90M-$100M 01/03/23 C.H. Robinson CEO Bob Biesterfeld steps down, Scott Anderson named interim CEO 11/17/22 C.H. Robinson raises quarterly dividend to 61c per share from 55c 11/02/22 C.H. Robinson sees $175M of gross cost savings in Q4 CCS Century Communities $63.32 / +2.215 (+3.63%) 10/27/22 Century Communities falls -12.0% 10/26/22 Century Communities CFO provides FY22 outlook ALGN Align Technology $282.22 / +12.72 (+4.72%) 02/01/23 Align Technology board authorizes $1B buyback to succeed current program 10/31/22 Align Technology CEO Joe Hogan to purchase additional $2M of common stock 10/31/22 Align Technology announces $200M accelerated share repurchase agreement 10/26/22 Align Technology falls 20% to $177.50 after Q3 results misses estimates META ALGN ELF EZPW EGHT IVAC HOLX CLB MCK TENX CHX MXL PTC CHRW CTVA QRVO CCS VERA ROIV META Meta Platforms $153.10 / +4.135 (+2.78%) 01/31/23 LightShed Partners Meta Platforms initiated with a Buy at LightShed Partners 01/30/23 DA Davidson DA Davidson neutral on Pinterest ahead of earnings 01/27/23 BofA BuzzFeed still a 'show me story,' Meta deal not new, says BofA 01/26/23 Piper Sandler Meta Platforms price target raised to $136 from $116 at Piper Sandler ALGN Align Technology $282.22 / +12.72 (+4.72%) 01/11/23 Piper Sandler Align Technology price target raised to $255 from $230 at Piper Sandler 10/27/22 Stifel Align Technology price target lowered to $265 from $325 at Stifel 10/27/22 Baird Align Technology price target lowered to $260 from $310 at Baird 10/27/22 Piper Sandler Align Technology price target lowered to $230 from $300 at Piper Sandler ELF e.l.f. Beauty $58.56 / +0.94 (+1.63%) 01/24/23 Stifel e.l.f. Beauty price target raised to $50 from $43 at Stifel 01/13/23 JPMorgan e.l.f. Beauty price target raised to $65 from $62 at JPMorgan 01/09/23 Jefferies e.l.f. Beauty downgraded to Hold from Buy at Jefferies 01/03/23 Piper Sandler e.l.f. Beauty price target raised to $64 from $55 at Piper Sandler EZPW Ezcorp $9.02 / -0.08 (-0.88%) 01/04/23 Canaccord Canaccord starts Ezcorp with a Buy, says discount 'undeserved' 01/04/23 Canaccord Ezcorp initiated with a Buy at Canaccord 04/05/22 Jefferies Ezcorp upgraded to Buy from Hold at Jefferies EGHT 8x8 $5.01 / +0.285 (+6.03%) 12/15/22 Wedbush Wedbush starts 8x8 with a Neutral as momentum slows 12/14/22 Wedbush 8x8 initiated with a Neutral at Wedbush 12/02/22 Craig-Hallum Craig-Hallum sees 'tremendous logic' in RingCentral, 8x8 combination 10/28/22 Barclays 8x8 price target lowered to $4 from $5 at Barclays IVAC Intevac $6.80 / -0.06 (-0.87%) 01/03/23 Benchmark Intevac upgraded to Buy at Benchmark following TRIO agreement 01/03/23 Benchmark Intevac upgraded to Buy from Hold at Benchmark 02/10/22 Benchmark Intevac downgraded to Hold from Buy at Benchmark HOLX Hologic $82.85 / +1.47 (+1.81%) 01/24/23 Mizuho Hologic price target raised to $90 from $77 at Mizuho 01/10/23 Wells Fargo Hologic price target raised to $80 from $75 at Wells Fargo 12/06/22 RBC Capital Hologic initiated with a Sector Perform at RBC Capital 11/16/22 Evercore ISI Evercore ISI removes seven Healthcare Services and Tech stocks from 'TAP' list CLB Core Laboratories $25.86 / +0.29 (+1.13%) 01/09/23 BofA Core Laboratories upgraded to Neutral from Underperform at BofA 10/07/22 Piper Sandler Core Laboratories assumed with a Neutral at Piper Sandler 10/06/22 Citi Citi upgrades Core Laboratories to Neutral following pullback 10/06/22 Citi Core Laboratories upgraded to Neutral from Sell at Citi MCK McKesson $370.85 / -7.73 (-2.04%) 01/31/23 UBS McKesson price target lowered to $440 from $450 at UBS 01/11/23 Baird McKesson price target raised to $445 from $440 at Baird 11/14/22 Mizuho McKesson price target raised to $376 from $345 at Mizuho 11/02/22 TD Cowen McKesson price target raised to $416 from $384 at Cowen TENX Tenax Therapeutics $1.70 / -0.37 (-17.87%) CHX ChampionX $32.47 / -0.54 (-1.64%) 11/01/22 Citi ChampionX price target raised to $34 from $30 at Citi 10/07/22 Piper Sandler ChampionX assumed with an Overweight at Piper Sandler 10/06/22 Barclays ChampionX downgraded on less potential upside potential at Barclays 10/06/22 Barclays ChampionX downgraded to Equal Weight from Overweight at Barclays MXL MaxLinear $43.25 / +2 (+4.85%) 11/02/22 Needham Silicon Motion upgraded to Buy at Needham after 'better than feared' report 10/26/22 Northland MaxLinear price target lowered to $35 from $45 at Northland 10/26/22 Craig-Hallum MaxLinear price target lowered to $55 from $65 at Craig-Hallum 10/26/22 Susquehanna MaxLinear price target lowered to $42 from $45 at Susquehanna PTC PTC $137.98 / +3.15 (+2.34%) 01/30/23 RBC Capital PTC price target raised to $155 from $140 at RBC Capital 01/26/23 Baird PTC price target raised to $165 from $150 at Baird 01/23/23 KeyBanc PTC upgraded to Overweight from Sector Weight at KeyBanc 01/11/23 Barclays PTC price target lowered to $144 from $148 at Barclays CHRW C.H. Robinson $101.99 / +1.755 (+1.75%) 01/17/23 BofA Schneider, Werner upgraded to Buy, XPO Logistics downgraded at BofA 01/17/23 BofA C.H. Robinson downgraded to Underperform from Neutral at BofA 01/11/23 JPMorgan C.H. Robinson downgraded to Neutral from Overweight at JPMorgan 01/11/23 KeyBanc C.H. Robinson price target lowered to $110 from $120 at KeyBanc CTVA Corteva $64.47 / +0.015 (+0.02%) 01/20/23 Citi Corteva price target lowered to $72 from $75 at Citi 01/18/23 Wells Fargo Corteva initiated with an Overweight at Wells Fargo 01/18/23 Wells Fargo Corteva initiated with an Overweight at Wells Fargo 01/11/23 BofA shakes up ratings to get 'more offensive' in U.S. Chemicals QRVO Qorvo $113.56 / +4.91 (+4.52%) 01/23/23 Barclays Qorvo price target raised to $110 from $85 at Barclays 01/17/23 Citi Citi opens 'positive catalyst watch' on Qorvo 01/11/23 KeyBanc KeyBanc says iPhone survey shows supply partial recovery, some shortages remain 01/09/23 Wells Fargo Qorvo price target raised to $90 from $80 at Wells Fargo CCS Century Communities $63.32 / +2.215 (+3.63%) 01/20/23 B. Riley Century Communities price target raised to $49 from $44 at B. Riley 12/30/22 Wedbush Wedbush favors four homebuilding stocks heading into 2023 11/29/22 BTIG Century Communities initiated with a Neutral at BTIG 11/22/22 JPMorgan Century Communities downgraded to Underweight from Overweight at JPMorgan VERA Vera Therapeutics $8.47 / -0.01 (-0.12%) 01/04/23 Jefferies Vera Therapeutics downgraded to Hold from Buy at Jefferies 01/04/23 Wedbush Wedbush downgrades Vera Therapeutics to Neutral, lowers price target to $8 01/04/23 Wedbush Vera Therapeutics downgraded to Neutral from Outperform at Wedbush 01/04/23 H.C. Wainwright Vera Therapeutics price target lowered to $15 from $36 at H.C. Wainwright ROIV Roivant Sciences $8.57 / +0.275 (+3.32%) 01/05/23 Citi Roivant Sciences price target raised to $14 from $11 at Citi 01/04/23 Piper Sandler Prometheus, Roivant TL1A data look 'highly competitive,' says Piper 12/28/22 Cantor Fitzgerald Cantor calls Merck top large cap pharma pick, names 8 SMID cap top picks 12/27/22 Cantor Fitzgerald Roivant's upcoming data readouts could move stock higher, says Cantor Fitzgerald VERA ROIV QRVO PTC MXL META MCK IVAC HOLX EZPW ELF EGHT CTVA CLB CHX CHRW CCS ALGN VERA Vera Therapeutics $8.47 / -0.01 (-0.12%) 11/09/22 Vera Therapeutics reports Q3 EPS (91c), consensus (72c) 08/10/22 Vera Therapeutics reports Q2 EPS (55c) vs (33c) last year ROIV Roivant Sciences $8.57 / +0.275 (+3.32%) 11/14/22 Roivant Sciences reports Q2 EPS (42c), consensus (41c) 08/15/22 Roivant Sciences reports Q1 EPS (48c) vs (13c) last year QRVO Qorvo $113.56 / +4.91 (+4.52%) 02/01/23 Qorvo sees Q4 EPS 10c-15c, consensus 64c 02/01/23 Qorvo reports Q3 EPS 75c, consensus 63c 11/02/22 Qorvo sees Q3 EPS 50c-75c, consensus $1.69 PTC PTC $137.98 / +3.15 (+2.34%) 02/01/23 PTC raises FY23 revenue view to $2.070B-$2.150B from $2.050B-$2.130B 02/01/23 PTC reports Q1 adjusted EPS 99c, consensus $1.03 11/02/22 PTC sees FY23 revenue $1.91B-$1.99B, consensus $1.92B 11/02/22 PTC reports Q4 adjusted EPS $1.27, consensus $1.15 MXL MaxLinear $43.25 / +2 (+4.85%) 02/01/23 MaxLinear sees Q1 revenue $240M-$260M, consesus $279.7M 02/01/23 MaxLinear reports Q4 adjusted EPS $1.07, consensus $1.06 10/25/22 MaxLinear sees Q4 revenue $285M-$295M, consensus $285.36M 10/25/22 MaxLinear reports Q3 EPS $1.05, consensus $1.04 META Meta Platforms $153.10 / +4.135 (+2.78%) 02/01/23 Meta Platforms sees Q1 revenue $26B-$28.5B, consensus $27.14B 02/01/23 Meta Platforms reports Q4 EPS $1.76, consensus $2.22 02/01/23 Notable companies reporting after market close 11/09/22 Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B MCK McKesson $370.85 / -7.73 (-2.04%) 02/01/23 McKesson raises FY23 EPS view to $25.75-$26.15 from $24.45-$24.95 02/01/23 McKesson reports Q3 adjusted EPS $6.90, consensus $6.35 11/01/22 McKesson boosts FY23 adjusted EPS view to $24.45-$24.95 from $23.95-$24.65 IVAC Intevac $6.80 / -0.06 (-0.87%) 02/01/23 Intevac sees Q1 EPS (20c)-(16c), consensus (21c) 02/01/23 Intevac reports Q4 EPS (13c) vs. (25c) y/y 11/02/22 Intevac sees Q4 EPS (21c)-(17c), consensus (12c) 08/03/22 Intevac sees Q3 EPS (17c) to (15c), one estimate (13c) HOLX Hologic $82.85 / +1.47 (+1.81%) 02/01/23 Hologic raises FY23 EPS view to $3.55-$3.85 from $3.30-$3.60 02/01/23 Hologic sees Q2 adjusted EPS 80c-90c, consensus 82c 02/01/23 Hologic reports Q1 adjusted EPS $1.07, consensus 91c 01/08/23 Hologic reports preliminary Q1 revenue $1.074B, consensus $966.37M EZPW Ezcorp $9.02 / -0.08 (-0.88%) 02/01/23 Ezcorp reports Q1 adjusted EPS 28c, consensus 22c 11/16/22 Ezcorp reports Q4 adjusted EPS 15c, one estimate 12c 08/03/22 Ezcorp reports Q3 adjusted EPS 16c, consensus 5c ELF e.l.f. Beauty $58.56 / +0.94 (+1.63%) 02/01/23 e.l.f. Beauty raises FY23 adjusted EPS view to $1.37-$1.40 from $1.07-$1.10 02/01/23 e.l.f. Beauty reports Q3 adjusted EPS 48c, consensus 23c 11/02/22 e.l.f. Beauty raises FY23 EPS view to $1.07-$1.10 from 84c-87c 11/02/22 e.l.f. Beauty reports Q2 EPS 36c, consensus 16c EGHT 8x8 $5.01 / +0.285 (+6.03%) 02/01/23 8x8 raises FY23 revenue view to $743.4M-$746.4M from $720M-$730M 02/01/23 8x8 sees Q4 revenue $184M-$187M, consensus $187.67M 02/01/23 8x8 reports Q3 adjusted EPS 7c, consensus 3c CTVA Corteva $64.47 / +0.015 (+0.02%) 02/01/23 Corteva sees FY23 operating EPS $2.70-$2.90, consensus $3.13 02/01/23 Corteva reports Q4 adjusted EPS 16c, consensus 5c 11/03/22 Corteva backs FY22 adjusted EPS view $2.45-$2.60, consensus $2.57 11/03/22 Corteva reports Q3 adjusted EPS (12c), consensus (23c) CLB Core Laboratories $25.86 / +0.29 (+1.13%) 02/01/23 Core Laboratories reports Q4 EPS 20c, consensus 20c 10/26/22 Core Laboratories reports Q3 EPS 18c, consensus 15c CHX ChampionX $32.47 / -0.54 (-1.64%) 02/01/23 ChampionX sees Q1 revenue $952M-$982M, consensus $994.58M 02/01/23 ChampionX reports Q4 EPS 33c, consensus 40c 10/25/22 ChampionX sees Q4 revenue $985M-$1.015B, consensus $953.01M 10/25/22 ChampionX reports Q3 adjusted EPS 33c, consensus 32c CHRW C.H. Robinson $101.99 / +1.755 (+1.75%) 02/01/23 C.H. Robinson reports Q4 adjusted EPS $1.03, consensus $1.38 11/02/22 C.H. Robinson reports Q3 EPS $1.78, consensus $2.17 CCS Century Communities $63.32 / +2.215 (+3.63%) 02/01/23 Century Communities reports Q4 adjusted EPS $2.71, consensus $2.43 10/26/22 Century Communities reports Q3 EPS $4.44, consensus $4.20 ALGN Align Technology $282.22 / +12.72 (+4.72%) 02/01/23 Align Technology reports Q4 EPS $1.73, consensus $1.56 10/26/22 Align Technology reports Q3 adjusted EPS $1.36, consensus $2.18 03 Feb 02 Feb 08 Nov 10 Feb META HOLX CHRW META Meta Platforms $153.10 / +4.135 (+2.78%) 02/01/23 GoodRx to pay $1.5M fine over sharing health data, Bloomberg Law reports 02/01/23 Meta wins approval over FTC to acquire Within Unlimited, Bloomberg says 02/01/23 Meta debates on whether to share Reel money with creators, Information reports 01/31/23 Reels sharing revenue with creators hotly debated within Meta, Information says HOLX Hologic $82.85 / +1.47 (+1.81%) 10/22/22 Hologic still not losing steam as other COVID companies have, Barron's says CHRW C.H. Robinson $101.99 / +1.755 (+1.75%) 01/10/23 C.H. Robinson reaches standstill agreement with Ancora, WSJ reports VERA TENX ROIV QRVO PTC MXL META HOLX EZPW ELF EGHT CTVA CLB CHX CHRW ALGN VERA Vera Therapeutics $8.47 / -0.01 (-0.12%) 01/04/23 What You Missed On Wall Street On Wednesday 01/04/23 What You Missed On Wall Street This Morning 01/04/23 Fly Intel: Pre-market Movers 01/03/23 Fly Intel: After-Hours Movers TENX Tenax Therapeutics $1.70 / -0.37 (-17.87%) 01/06/23 Biotech Alert: Searches spiking for these stocks today 11/18/22 Biotech Alert: Searches spiking for these stocks today 11/07/22 Biotech Alert: Searches spiking for these stocks today ROIV Roivant Sciences $8.57 / +0.275 (+3.32%) 11/14/22 Fly Intel: Pre-market Movers 10/27/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 09/19/22 Fly Intel: After-Hours Movers QRVO Qorvo $113.56 / +4.91 (+4.52%) 11/19/22 Buy/Sell: Wall Street's top 10 stock calls this week 11/16/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/05/22 Buy/Sell: Wall Street's top 10 stock calls this week 11/03/22 What You Missed On Wall Street On Thursday PTC PTC $137.98 / +3.15 (+2.34%) 01/23/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations MXL MaxLinear $43.25 / +2 (+4.85%) 10/05/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations META Meta Platforms $153.10 / +4.135 (+2.78%) 02/01/23 What You Missed On Wall Street On Wednesday 02/01/23 #SocialStocks: Meta circumvents FTC challenge and will acquire Within Unlimited 02/01/23 What You Missed On Wall Street This Morning 01/31/23 What You Missed On Wall Street On Tuesday HOLX Hologic $82.85 / +1.47 (+1.81%) 11/01/22 What You Missed On Wall Street On Tuesday 11/01/22 What You Missed On Wall Street This Morning 10/31/22 Fly Intel: After-Hours Movers EZPW Ezcorp $9.02 / -0.08 (-0.88%) 08/03/22 Fly Intel: After-Hours Movers ELF e.l.f. Beauty $58.56 / +0.94 (+1.63%) 01/09/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 10/11/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 09/14/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/12/22 What You Missed On Wall Street On Friday EGHT 8x8 $5.01 / +0.285 (+6.03%) 10/28/22 What You Missed On Wall Street On Friday 10/28/22 What You Missed On Wall Street This Morning 10/27/22 Fly Intel: After-Hours Movers CTVA Corteva $64.47 / +0.015 (+0.02%) 11/15/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/08/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/04/22 Fly Intel: After-Hours Movers CLB Core Laboratories $25.86 / +0.29 (+1.13%) 10/07/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations CHX ChampionX $32.47 / -0.54 (-1.64%) 10/25/22 Fly Intel: After-Hours Movers CHRW C.H. Robinson $101.99 / +1.755 (+1.75%) 01/11/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 09/15/22 Fly Intel: After-Hours Movers ALGN Align Technology $282.22 / +12.72 (+4.72%) 10/27/22 What You Missed On Wall Street On Thursday 10/27/22 What You Missed On Wall Street This Morning 10/26/22 Fly Intel: After-Hours Movers 02/16/23 MedTech, Digital Health, Life Sciences & Diagnostic Tools Conference 03/12/23 35th Annual Roth Conference 03/17/23 2023 AAD Annual Meeting 02/01/23 McKesson - MCK 02/01/23 Hologic - HOLX 02/01/23 Align Technology - ALGN 02/01/23 MaxLinear - MXL 02/01/23 e.l.f. Beauty - ELF 02/01/23 8x8 - EGHT 02/01/23 Intevac - IVAC 02/01/23 Century Communities - CCS 02/01/23 Meta Platforms - META 02/01/23 C.H. Robinson - CHRW 02/01/23 PTC - PTC 02/01/23 Qorvo - QRVO 02/02/23 Core Laboratories - CLB 02/02/23 Corteva - CTVA 02/02/23 ChampionX - CHX 02/02/23 Ezcorp - EZPW 02/13/23 Roivant Sciences - ROIV 02/16/23 PTC Inc 03/09/23 Hologic Inc QRVO META MCK HOLX ELF CTVA CHRW ALGN QRVO Qorvo $113.56 / +4.91 (+4.52%) 02/01/23 Qorvo options imply 5.2% move in share price post-earnings META Meta Platforms $153.10 / +4.135 (+2.78%) 02/01/23 Meta Platforms (Facebook) options imply 8.9% move in share price post-earnings 01/10/23 Notable open interest changes for January 10th 01/04/23 Meta Platforms (Facebook) call volume above normal and directionally bullish 12/16/22 Early notable gainers among liquid option names on December 16th MCK McKesson $370.85 / -7.73 (-2.04%) 02/01/23 McKesson options imply 2.6% move in share price post-earnings 11/14/22 Early notable gainers among liquid option names on November 14th 08/04/22 Early notable gainers among liquid option names on August 4th HOLX Hologic $82.85 / +1.47 (+1.81%) 02/01/23 Hologic options imply 3.5% move in share price post-earnings 11/01/22 Early notable gainers among liquid option names on November 1st ELF e.l.f. Beauty $58.56 / +0.94 (+1.63%) 02/01/23 E.l.f. Beauty options imply 7.6% move in share price post-earnings CTVA Corteva $64.47 / +0.015 (+0.02%) 02/01/23 Corteva options imply 2.7% move in share price post-earnings 09/13/22 Early notable gainers among liquid option names on September 13th 08/05/22 Early notable gainers among liquid option names on August 5th CHRW C.H. Robinson $101.99 / +1.755 (+1.75%) 02/01/23 CH Robinson Worldwide options imply 6.1% move in share price post-earnings ALGN Align Technology $282.22 / +12.72 (+4.72%) 02/01/23 Align Technology options imply 9.2% move in share price post-earnings 10/31/22 Early notable gainers among liquid option names on October 31st 10/26/22 Align Technology options imply 11.2% move in share price post-earnings 09/26/22 Align Technology call volume above normal and directionally bullish
Earnings	Intevac sees Q1 EPS (20c)-(16c), consensus (21c) » 17:07 02/01/23 02/01 17:07 02/01/23 17:07 IVAC Intevac $6.80 / -0.06 (-0.87%) Sees Q1 revenue… Sees Q1 revenue $10.5M-$11.5M, consensus $7.05M. Sees Q1 gross margin 40%-42%. Sees Q1 operating expense $9M-$9.5M. Says after Q1 expects operating expense to be $9M for rest of FY23. Sees FY23 gross margin 40%. Says 2022 was transformational. Comments and guidance taken from Q4 earnings conference call. ShowHide Related Items >><< Company News Street Research Earnings Events IVAC Intevac $6.80 / -0.06 (-0.87%) 12/30/22 Intevac signs joint development agreement with glass, glass ceramic provider 10/26/22 Intevac gets $12M order for hard disk drive technology upgrades IVAC Intevac $6.80 / -0.06 (-0.87%) 01/03/23 Benchmark Intevac upgraded to Buy at Benchmark following TRIO agreement 01/03/23 Benchmark Intevac upgraded to Buy from Hold at Benchmark 02/10/22 Benchmark Intevac downgraded to Hold from Buy at Benchmark IVAC Intevac $6.80 / -0.06 (-0.87%) 02/01/23 Intevac reports Q4 EPS (13c) vs. (25c) y/y 11/02/22 Intevac sees Q4 EPS (21c)-(17c), consensus (12c) 08/03/22 Intevac sees Q3 EPS (17c) to (15c), one estimate (13c) 08/03/22 Intevac reports Q2 EPS (11c), one estimate (15c) 02/01/23 Intevac - IVAC
Earnings	Intevac reports Q4 EPS (13c) vs. (25c) y/y » 16:13 02/01/23 02/01 16:13 02/01/23 16:13 IVAC Intevac $6.78 / -0.08 (-1.17%) Reports Q4 revenue $11.3M… Reports Q4 revenue $11.3M vs. $15.9M y/y. "The fourth quarter marked a great finish to 2022, culminating in the completion of the joint development agreement for our ground-breaking TRIO(TM) platform," said Nigel Hunton, CEO. "The TRIO provides an innovation in technology for the coating of glass and glass ceramic materials on consumer devices that builds upon our decades of materials science expertise in high-productivity manufacturing environments. The agreement includes approximately $100 million in system revenue over five years, in order for our customer to maintain exclusive access to the TRIO platform for consumer electronics applications. The record level of orders and backlog for our HDD business in 2022 established a solid foundation for growth for the next several years, and we look forward to gaining momentum in both businesses in 2023 in order to position Intevac for a major growth year in 2024, which is when we expect to return to a full year of profitable and cash-flow positive results. Finally, the strength of our balance sheet remains critically important to our customers, partners, suppliers, and stockholders, and we are pleased to report a net use of cash of only $8 million over the course of 2022. We will continue to maintain a strong balance sheet as we make the necessary investments for transformational growth ahead." ShowHide Related Items >><< Company News Street Research Earnings Events IVAC Intevac $6.78 / -0.08 (-1.17%) 12/30/22 Intevac signs joint development agreement with glass, glass ceramic provider 10/26/22 Intevac gets $12M order for hard disk drive technology upgrades IVAC Intevac $6.78 / -0.08 (-1.17%) 01/03/23 Benchmark Intevac upgraded to Buy at Benchmark following TRIO agreement 01/03/23 Benchmark Intevac upgraded to Buy from Hold at Benchmark 02/10/22 Benchmark Intevac downgraded to Hold from Buy at Benchmark IVAC Intevac $6.78 / -0.08 (-1.17%) 11/02/22 Intevac sees Q4 EPS (21c)-(17c), consensus (12c) 08/03/22 Intevac sees Q3 EPS (17c) to (15c), one estimate (13c) 08/03/22 Intevac reports Q2 EPS (11c), one estimate (15c) 02/01/23 Intevac - IVAC
Upgrade	Intevac upgraded to Buy at Benchmark following TRIO agreement » 08:32 01/03/23 01/03 08:32 01/03/23 08:32 IVAC Intevac $6.49 / +0.23 (+3.67%) Benchmark analyst Mark… Benchmark analyst Mark Miller upgraded Intevac to Buy from Hold with a $9 price target after the company announced it has signed a joint development agreement with "a major provider of glass and glass ceramic materials" for its TRIO deposition tool. In addition to having a minimum revenue requirement of approximately $100M in system sales to Intevac over the five-year period, the agreement opens important new markets for Intevac, such as other glass coating applications for the automotive and point-of-sale display markets, Miller tells investors. ShowHide Related Items >><< Company News Street Research Earnings IVAC Intevac $6.49 / +0.23 (+3.67%) 12/30/22 Intevac signs joint development agreement with glass, glass ceramic provider 10/26/22 Intevac gets $12M order for hard disk drive technology upgrades IVAC Intevac $6.49 / +0.23 (+3.67%) 01/03/23 Benchmark Intevac upgraded to Buy from Hold at Benchmark 02/10/22 Benchmark Intevac downgraded to Hold from Buy at Benchmark IVAC Intevac $6.49 / +0.23 (+3.67%) 11/02/22 Intevac sees Q4 EPS (21c)-(17c), consensus (12c) 08/03/22 Intevac sees Q3 EPS (17c) to (15c), one estimate (13c) 08/03/22 Intevac reports Q2 EPS (11c), one estimate (15c)
Upgrade	Intevac upgraded to Buy from Hold at Benchmark » 07:41 01/03/23 01/03 07:41 01/03/23 07:41 IVAC Intevac $6.49 / +0.23 (+3.67%) Benchmark analyst Mark… Benchmark analyst Mark Miller upgraded Intevac to Buy from Hold with a $9 price target. ShowHide Related Items >><< Company News Street Research Earnings IVAC Intevac $6.49 / +0.23 (+3.67%) 12/30/22 Intevac signs joint development agreement with glass, glass ceramic provider 10/26/22 Intevac gets $12M order for hard disk drive technology upgrades IVAC Intevac $6.49 / +0.23 (+3.67%) 02/10/22 Benchmark Intevac downgraded to Hold from Buy at Benchmark IVAC Intevac $6.49 / +0.23 (+3.67%) 11/02/22 Intevac sees Q4 EPS (21c)-(17c), consensus (12c) 08/03/22 Intevac sees Q3 EPS (17c) to (15c), one estimate (13c) 08/03/22 Intevac reports Q2 EPS (11c), one estimate (15c)
Hot Stocks	Intevac signs joint development agreement with glass, glass ceramic provider » 09:19 12/30/22 12/30 09:19 12/30/22 09:19 IVAC Intevac $6.28 / -0.055 (-0.87%) Intevac announced it has… Intevac announced it has signed a joint development agreement with a provider of glass and glass ceramic materials. The company said, "While specific details of the terms of the partnership will remain confidential, the definitive agreement signed last week includes a five-year period of exclusivity for this key customer, who will deploy the TRIO(TM) for consumer electronics applications. In order to maintain exclusivity of the TRIO(TM) platform for this market, there is a minimum revenue requirement of approximately $100 million in system sales to Intevac over the five-year period. The selling price and gross margin profile of the TRIO(TM) is similar to that of its flagship 200 Lean(R) system. Intevac will continue to develop additional customer relationships for the TRIO(TM) for other glass coating applications, such as in the automotive and point-of-sale display markets." ShowHide Related Items >><< Company News Street Research Earnings IVAC Intevac $6.28 / -0.055 (-0.87%) 10/26/22 Intevac gets $12M order for hard disk drive technology upgrades IVAC Intevac $6.28 / -0.055 (-0.87%) 02/10/22 Benchmark Intevac downgraded to Hold from Buy at Benchmark IVAC Intevac $6.28 / -0.055 (-0.87%) 11/02/22 Intevac sees Q4 EPS (21c)-(17c), consensus (12c) 08/03/22 Intevac sees Q3 EPS (17c) to (15c), one estimate (13c) 08/03/22 Intevac reports Q2 EPS (11c), one estimate (15c)

Over a quarter ago
Earnings	Intevac sees Q4 EPS (21c)-(17c), consensus (12c) » 16:52 11/02/22 11/02 16:52 11/02/22 16:52 IVAC Intevac $4.42 / -0.015 (-0.34%) Sees Q4 revenue $10M,… Sees Q4 revenue $10M, consensus $11.5M. Sees Q4 gross margin 32%-34%. Sees Q4 operating expense $8M. Sees Q4 interest income $400,000. Sees cash at year end $105M-$110M. Says upgrades in Q1 will be down sequentially from Q4. Comments and guidance taken from Q3 earnings conference call. ShowHide Related Items >><< Company News Street Research Earnings Events IVAC Intevac $4.42 / -0.015 (-0.34%) 10/26/22 Intevac gets $12M order for hard disk drive technology upgrades 05/09/22 Intevac sees FY22 hard drive revenue around $35M IVAC Intevac $4.42 / -0.015 (-0.34%) 02/10/22 Benchmark Intevac downgraded to Hold from Buy at Benchmark IVAC Intevac $4.42 / -0.015 (-0.34%) 08/03/22 Intevac sees Q3 EPS (17c) to (15c), one estimate (13c) 08/03/22 Intevac reports Q2 EPS (11c), one estimate (15c) 05/09/22 Intevac sees Q2 EPS (15c)-(13c), one estimate (20c) 05/09/22 Intevac reports Q1 adjusted EPS (20c) vs (23c) last year 11/02/22 Intevac - IVAC
Hot Stocks	Intevac gets $12M order for hard disk drive technology upgrades » 09:05 10/26/22 10/26 09:05 10/26/22 09:05 IVAC Intevac $4.57 / +0.015 (+0.33%) Intevac announced the… Intevac announced the receipt of a $12M order for hard disk drive technology upgrades. Scheduled to be installed in 2023, these upgrades will provide enhanced capabilities for its 200 Lean installed base. "This order is a reflection of our close partnership with our HDD customers as we work together to enable achievement of their media technology roadmaps," said Nigel Hunton, president and chief executive officer. "We are pleased to be chosen as the premier technology provider for the next generation of HDD media. Our proven track record of strong execution in meeting our customers' needs, including delivering multiple 200 Lean process modules on an aggressive shipment schedule, is an important aspect of our continued leadership in providing the industry's most advanced media processing solutions." ShowHide Related Items >><< Company News Street Research Earnings Events IVAC Intevac $4.57 / +0.015 (+0.33%) 05/09/22 Intevac sees FY22 hard drive revenue around $35M 05/02/22 Intevac announces $11M order for 200 Lean systems IVAC Intevac $4.57 / +0.015 (+0.33%) 02/10/22 Benchmark Intevac downgraded to Hold from Buy at Benchmark IVAC Intevac $4.57 / +0.015 (+0.33%) 08/03/22 Intevac sees Q3 EPS (17c) to (15c), one estimate (13c) 08/03/22 Intevac reports Q2 EPS (11c), one estimate (15c) 05/09/22 Intevac sees Q2 EPS (15c)-(13c), one estimate (20c) 05/09/22 Intevac reports Q1 adjusted EPS (20c) vs (23c) last year 11/02/22 Intevac - IVAC
Earnings	Intevac sees Q3 EPS (17c) to (15c), one estimate (13c) » 17:06 08/03/22 08/03 17:06 08/03/22 17:06 IVAC Intevac $5.00 / +0.215 (+4.49%) Sees Q3 revenue… Sees Q3 revenue $9.5M-$10M, one estimate (10c). Sees FY22 revenue $35M, one estimate $35.4M. Guidance taken from investor presentation slides. ShowHide Related Items >><< Company News Street Research Earnings Events IVAC Intevac $5.00 / +0.215 (+4.49%) 05/09/22 Intevac sees FY22 hard drive revenue around $35M 05/02/22 Intevac announces $11M order for 200 Lean systems 04/04/22 Intevac receives $54M order for multiple 200 Lean systems 02/09/22 Intevac says deferring providing FY guidance until next quarterly call IVAC Intevac $5.00 / +0.215 (+4.49%) 02/10/22 Benchmark Intevac downgraded to Hold from Buy at Benchmark IVAC Intevac $5.00 / +0.215 (+4.49%) 08/03/22 Intevac reports Q2 EPS (11c), one estimate (15c) 05/09/22 Intevac sees Q2 EPS (15c)-(13c), one estimate (20c) 05/09/22 Intevac reports Q1 adjusted EPS (20c) vs (23c) last year 02/09/22 Intevac sees Q1 EPS (24c), one estimate (4c) 08/23/22 13th Annual BWS Financial Growth and Value Summer Investor Series 08/03/22 Intevac - IVAC
Earnings	Intevac reports Q2 EPS (11c), one estimate (15c) » 16:30 08/03/22 08/03 16:30 08/03/22 16:30 IVAC Intevac $5.00 / +0.215 (+4.49%) Reports Q2 revenue $9.3M,… Reports Q2 revenue $9.3M, one estimate $8.0M. "Given the recent softening in some areas of technology spending, we now expect our customers will spread their media capacity additions more evenly across the next three years, which we believe will result in continued year-over-year revenue growth for our HDD business as we look beyond 2022. Additional drivers for revenue growth beyond the HDD market are focused squarely on Intevac's proprietary TRIO(TM) technology and manufacturing platform, which we believe offers a compelling solution that addresses the display cover glass market's most pressing challenges. Our expertise and world-leading knowledge in materials science and creating highly precise and durable coatings from 30 years of HDD developments underpins this new innovation." CEO Nigel Hunton said, "We continue our targeted approach to increasing our revenue growth potential in order to move towards profitability and increased stockholder value. At the same time, we are steadfastly focused on streamlining the company, maintaining the strength of the balance sheet, and we continue to expect to end fiscal 2022 with a similarly strong cash position as year-end 2021." ShowHide Related Items >><< Company News Street Research Earnings Events IVAC Intevac $5.00 / +0.215 (+4.49%) 05/09/22 Intevac sees FY22 hard drive revenue around $35M 05/02/22 Intevac announces $11M order for 200 Lean systems 04/04/22 Intevac receives $54M order for multiple 200 Lean systems 02/09/22 Intevac says deferring providing FY guidance until next quarterly call IVAC Intevac $5.00 / +0.215 (+4.49%) 02/10/22 Benchmark Intevac downgraded to Hold from Buy at Benchmark IVAC Intevac $5.00 / +0.215 (+4.49%) 05/09/22 Intevac sees Q2 EPS (15c)-(13c), one estimate (20c) 05/09/22 Intevac reports Q1 adjusted EPS (20c) vs (23c) last year 02/09/22 Intevac sees Q1 EPS (24c), one estimate (4c) 02/09/22 Intevac reports Q4 adjusted EPS (29c), one estimate (7c) 08/23/22 13th Annual BWS Financial Growth and Value Summer Investor Series 08/03/22 Intevac - IVAC

On The Fly

News and insights, exclusive to thefly.com

17:57	Fly Intel: After-Hours Movers»
16:27	What You Missed On Wall Street On Monday»
12:04	What You Missed On Wall Street This Morning»
11:06	What You Missed This Week in EVs and Clean Energy»
09:57	Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations»

View all On The Fly Stories »

Upcoming
Events (10)

	Biotech Mountain Meeting
	2023 Enterprise Connect Conference & Expo
	Gulf Coast Casino Bus Tour
	Shop Talk
AUDC ...	Needham Hosted Company Meetings at 2023 Enterprise Connect Conference
	KeyBanc Hosted Company Meetings at Enterprise Connect
FIVN ...	Piper Sandler Hosted Company Meetings at 2023 Enterprise Connect
XYL	Xylem
ALKT	Alkami
PERF	Perfect Corp.

View all of today’s events »

Today’s
Syndicate (0)

No syndicate deals.

View this week’s syndicate »

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial